Recent projects at QSCL
Development of inhaled pharmaceuticals:
- consultancy and Ethics Committee work address both preclinical & clinical development
- regulatory testing strategies based on decades of experience in toxicology & metabolism using both the general & inhalation routes
- selection & management of EU CROs for toxicology and bioanalytical programmes
- recent projects on inhaled generics, diabetes, sexual dysfunction, and nasal toxicity and & anatomy
Development of excipients and technologies for new inhalation formulations:
- these projects related to UK & USA submissions for new technologies for inhalation therapy
- monitoring of literature includes regulatory affairs & conferences on inhaled powders and devices
- recent projects on several excipient candidates for inhalation formulations
Gene therapy:
- programme of preclinical evaluation of a vector for pulmonary administration
Lung metabolism:
- the effects of pulmonary p450 on toxicity were used to select candidate pesticides
Information services:
- projects in this area related to diabetes, nasal toxicity and anatomy, to pulmonary metabolism, and particularly to new iIhalation excipients and formulation technologies
- we are available for due diligence investigations and evaluation of novel commercial technologies
- 0ur database of over 2000 international contacts is available to support your research and development
- extensive experience in selection of contract laboratories; including specialist services in inhalation pharmacology & efficacy, and evaluation of preclinical QT prolongation
Scientific meetings:
- attendance at scientific meetings each quarter to update my customers on recent developments
- recent presentations include lectures on nasal anatomy, preclinical toxicology, and First-time-in-Man
- on-site training modules can also be provided - please let us know of your interests. Enhanced computer systems and formal teaching qualifications facilitate high-quality individual presentations